Trials / Recruiting
RecruitingNCT06220266
Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Dhurakij Pundit University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to learn about the effects of phytoestrogen from Pueraria Mirifica in improvement of serum lipid parameters. The primary question it aims to answer are: • phytoestrogen from Pueraria Mirifica can reduce serum triglyceride, total cholesterol, LDL and increase HDL or not Participants will receive capsules which composed of dry weight 50 mg of Pueraria Mirifica twice a day for 2 months. Researchers will compare with diet control\&life style modification to see if there is the improvement of serum lipid parameters
Detailed description
The secondary question it aims to answer are: * phytoestrogen from Pueraria Mirifica can reduce menopausal symptom score or not * phytoestrogen from Pueraria Mirifica can reduce body mass index(BMI) or not * phytoestrogen from Pueraria Mirifica can reduce waist circumference or not * phytoestrogen from Pueraria Mirifica can reduce blood pressure or not * phytoestrogen from Pueraria Mirifica effects to creatinine, BUN, eGFR or not * phytoestrogen from Pueraria Mirifica effects liver function enzymes or not
Conditions
- Dyslipidemias
- Hypertriglyceridemia
- Hypercholesterolemia
- Hyper-LDL-cholesterolemia
- Hypo HDL Cholesterolaemia
- Postmenopausal Symptoms
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Phytoestrogen | consume 1 capsule twice a day for 2 months which one capsule composed of dry weight 50 mg of Pueraria Mirifica 1or Pueraria Mirifica 2 or Pueraria Mirifica 3 |
| DRUG | Diet control & life style modification | Diet control \& life style modification |
Timeline
- Start date
- 2024-03-02
- Primary completion
- 2024-08-01
- Completion
- 2024-11-01
- First posted
- 2024-01-23
- Last updated
- 2024-05-24
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT06220266. Inclusion in this directory is not an endorsement.